Previous Article | Next Article 
Journal of Virology, April 2005, p. 3969-3978, Vol. 79, No. 7
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.7.3969-3978.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKK
Adrien Breiman,1
Nathalie Grandvaux,2
Rongtuan Lin,2
Catherine Ottone,1
Shizuo Akira,3
Mitsutoshi Yoneyama,4
Takashi Fujita,4
John Hiscott,2* and
Eliane F. Meurs1*
Unité Hépacivirus, Institut Pasteur, Paris, France,1
Lady Davis Institute for Medical Research and Departments of Microbiology & Immunology and Medicine, McGill University, Montreal, Canada,2
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka,3
Department of Tumor Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo Metropolitan Organization for Medical Research, Bunkyo-ku, Japan4
Received 18 August 2004/
Accepted 6 November 2004
Interferon (IFN) is one important effector of the innate immune response, induced by different viral or bacterial components through Toll-like receptor (TLR)-dependent and -independent mechanisms. As part of its pathogenic strategy, hepatitis C virus (HCV) interferes with the innate immune response and induction of IFN-ß via the HCV NS3/4A protease activity which inhibits phosphorylation of IRF-3, a key transcriptional regulator of the IFN response. In the present study, we demonstrate that inhibition by the protease occurs upstream of the noncanonical IKK-related kinases IKK
and TBK-1, which phosphorylate IRF-3, through partial inhibition of the TLR adapter protein TRIF/TICAM1-dependent pathway. Use of TRIF/ mouse embryo fibroblasts however revealed the presence of a TRIF-independent pathway involved in IFN induction that was also inhibited by NS3/4A. Importantly, we show that NS3/4A can strongly inhibit the ability of the recently described RIG-I protein to activate IFN, suggesting that RIG-I is a key factor in the TRIF-independent, NS3/4A-sensitive pathway. Expression of IFN signaling components including IKK
, TBK-1, TRIF, and wild type or constitutively active forms of RIG-I in the HCV replicon cells resulted in IFN-ß promoter transactivation, with IKK
displaying the highest efficiency. Subsequently, overexpression of IKK
resulted in 80% inhibition of both the positive and negative replicative strands of the HCV replicon. The partial restoration of the capacity of the host cell to transcribe IFN-ß indicates that IKK
expression is able to bypass the HCV-mediated inhibition and restore the innate antiviral response.
* Corresponding author. Mailing address for E. Meurs: Unité Hépacivirus, Institut Pasteur, 75724 Paris Cedex 15, France. Phone: 33145688777, Fax: 33140613012. E-mail:
emeurs{at}pasteur.fr. Mailing address for J. Hiscott: Lady Davis Institute, McGill University, Montreal H3T 1E2, Quebec, Canada. Phone: (514) 340-8222, ext. 5265. Fax: (514) 340-7576. E-mail:
john.hiscott{at}mcgill.ca.
Journal of Virology, April 2005, p. 3969-3978, Vol. 79, No. 7
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.7.3969-3978.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Vitour, D., Dabo, S., Ahmadi Pour, M., Vilasco, M., Vidalain, P.-O., Jacob, Y., Mezel-Lemoine, M., Paz, S., Arguello, M., Lin, R., Tangy, F., Hiscott, J., Meurs, E. F.
(2009). Polo-like Kinase 1 (PLK1) Regulates Interferon (IFN) Induction by MAVS. J. Biol. Chem.
284: 21797-21809
[Abstract]
[Full Text]
-
Guo, J.-P., Shu, S.-K., He, L., Lee, Y.-C., Kruk, P. A., Grenman, S., Nicosia, S. V., Mor, G., Schell, M. J., Coppola, D., Cheng, J. Q.
(2009). Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer. Am. J. Pathol.
175: 324-333
[Abstract]
[Full Text]
-
Stacey, A. R., Norris, P. J., Qin, L., Haygreen, E. A., Taylor, E., Heitman, J., Lebedeva, M., DeCamp, A., Li, D., Grove, D., Self, S. G., Borrow, P.
(2009). Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections. J. Virol.
83: 3719-3733
[Abstract]
[Full Text]
-
Liao, S., Bao, X., Liu, T., Lai, S., Li, K., Garofalo, R. P., Casola, A.
(2008). Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J. Gen. Virol.
89: 1978-1986
[Abstract]
[Full Text]
-
Tasaka, M., Sakamoto, N., Itakura, Y., Nakagawa, M., Itsui, Y., Sekine-Osajima, Y., Nishimura-Sakurai, Y., Chen, C.-H., Yoneyama, M., Fujita, T., Wakita, T., Maekawa, S., Enomoto, N., Watanabe, M.
(2007). Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. J. Gen. Virol.
88: 3323-3333
[Abstract]
[Full Text]
-
Matsumiya, T., Prescott, S. M., Stafforini, D. M.
(2007). IFN-{epsilon} Mediates TNF-{alpha}-Induced STAT1 Phosphorylation and Induction of Retinoic Acid-Inducible Gene-I in Human Cervical Cancer Cells. J. Immunol.
179: 4542-4549
[Abstract]
[Full Text]
-
Tellinghuisen, T. L., Evans, M. J., von Hahn, T., You, S., Rice, C. M.
(2007). Studying Hepatitis C Virus: Making the Best of a Bad Virus. J. Virol.
81: 8853-8867
[Full Text]
-
Breakwell, L., Dosenovic, P., Karlsson Hedestam, G. B., D'Amato, M., Liljestrom, P., Fazakerley, J., McInerney, G. M.
(2007). Semliki Forest Virus Nonstructural Protein 2 Is Involved in Suppression of the Type I Interferon Response. J. Virol.
81: 8677-8684
[Abstract]
[Full Text]
-
Tamassia, N., Le Moigne, V., Calzetti, F., Donini, M., Gasperini, S., Ear, T., Cloutier, A., Martinez, F. O., Fabbri, M., Locati, M., Mantovani, A., McDonald, P. P., Cassatella, M. A.
(2007). The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4. J. Immunol.
178: 7344-7356
[Abstract]
[Full Text]
-
Guo, B., Cheng, G.
(2007). Modulation of the Interferon Antiviral Response by the TBK1/IKKi Adaptor Protein TANK. J. Biol. Chem.
282: 11817-11826
[Abstract]
[Full Text]
-
Aguilar, P. V., Weaver, S. C., Basler, C. F.
(2007). Capsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene Expression. J. Virol.
81: 3866-3876
[Abstract]
[Full Text]
-
Ciccaglione, A. R., Stellacci, E., Marcantonio, C., Muto, V., Equestre, M., Marsili, G., Rapicetta, M., Battistini, A.
(2007). Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes. J. Virol.
81: 202-214
[Abstract]
[Full Text]
-
Breiman, A., Vitour, D., Vilasco, M., Ottone, C., Molina, S., Pichard, L., Fournier, C., Delgrange, D., Charneau, P., Duverlie, G., Wychowski, C., Maurel, P., Meurs, E. F.
(2006). A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells. J. Gen. Virol.
87: 3587-3598
[Abstract]
[Full Text]
-
Paladino, P., Cummings, D. T., Noyce, R. S., Mossman, K. L.
(2006). The IFN-Independent Response to Virus Particle Entry Provides a First Line of Antiviral Defense That Is Independent of TLRs and Retinoic Acid-Inducible Gene I. J. Immunol.
177: 8008-8016
[Abstract]
[Full Text]
-
Taylor, R. T., Bresnahan, W. A.
(2006). Human Cytomegalovirus IE86 Attenuates Virus- and Tumor Necrosis Factor Alpha-Induced NF{kappa}B-Dependent Gene Expression.. J. Virol.
80: 10763-10771
[Abstract]
[Full Text]
-
Deng, L., Nagano-Fujii, M., Tanaka, M., Nomura-Takigawa, Y., Ikeda, M., Kato, N., Sada, K., Hotta, H.
(2006). NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J. Gen. Virol.
87: 1703-1713
[Abstract]
[Full Text]
-
Lin, R., Lacoste, J., Nakhaei, P., Sun, Q., Yang, L., Paz, S., Wilkinson, P., Julkunen, I., Vitour, D., Meurs, E., Hiscott, J.
(2006). Dissociation of a MAVS/IPS-1/VISA/Cardif-IKK{varepsilon} Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage.. J. Virol.
80: 6072-6083
[Abstract]
[Full Text]
-
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S., Colonna, M.
(2006). Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA
103: 8459-8464
[Abstract]
[Full Text]
-
Matikainen, S., Siren, J., Tissari, J., Veckman, V., Pirhonen, J., Severa, M., Sun, Q., Lin, R., Meri, S., Uze, G., Hiscott, J., Julkunen, I.
(2006). Tumor Necrosis Factor Alpha Enhances Influenza A Virus-Induced Expression of Antiviral Cytokines by Activating RIG-I Gene Expression.. J. Virol.
80: 3515-3522
[Abstract]
[Full Text]
-
Lin, R., Yang, L., Nakhaei, P., Sun, Q., Sharif-Askari, E., Julkunen, I., Hiscott, J.
(2006). Negative Regulation of the Retinoic Acid-inducible Gene I-induced Antiviral State by the Ubiquitin-editing Protein A20. J. Biol. Chem.
281: 2095-2103
[Abstract]
[Full Text]
-
Machida, K., Cheng, K. T. H., Sung, V. M.-H., Levine, A. M., Foung, S., Lai, M. M. C.
(2006). Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6. J. Virol.
80: 866-874
[Abstract]
[Full Text]
-
Li, X.-D., Sun, L., Seth, R. B., Pineda, G., Chen, Z. J.
(2005). From the Cover: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA
102: 17717-17722
[Abstract]
[Full Text]
-
Honda, K., Yanai, H., Takaoka, A., Taniguchi, T.
(2005). Regulation of the type I IFN induction: a current view. Int Immunol
17: 1367-1378
[Abstract]
[Full Text]
-
Fensterl, V., Grotheer, D., Berk, I., Schlemminger, S., Vallbracht, A., Dotzauer, A.
(2005). Hepatitis A Virus Suppresses RIG-I-Mediated IRF-3 Activation To Block Induction of Beta Interferon. J. Virol.
79: 10968-10977
[Abstract]
[Full Text]
-
Welbourn, S., Green, R., Gamache, I., Dandache, S., Lohmann, V., Bartenschlager, R., Meerovitch, K., Pause, A.
(2005). Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication. J. Biol. Chem.
280: 29604-29611
[Abstract]
[Full Text]